A Phase I Open Label Pilot Study to Evaluate the Safety, Efficacy and Tolerability of Anginera for Adults With Left Ventricular Dysfunction AND Reversible Myocardial Ischemia Undergoing CABG Surgery

Trial Profile

A Phase I Open Label Pilot Study to Evaluate the Safety, Efficacy and Tolerability of Anginera for Adults With Left Ventricular Dysfunction AND Reversible Myocardial Ischemia Undergoing CABG Surgery

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 27 May 2014

At a glance

  • Drugs Fibroblast cell therapy (Primary)
  • Indications Left ventricular dysfunction; Myocardial ischaemia
  • Focus Adverse reactions
  • Sponsors Theregen
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 27 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top